Pathway OME Announces Strategic Partnership with Standard Process and Rainbow Genomics

SAN DIEGO--(BUSINESS WIRE)-- Pathway OME announces their strategic partnership with Standard Process and Rainbow Genomics, respectively. Pathway OME is the leading genetic wellness company for nutrition, exercise, skincare and Artificial Intelligence (AI), used to help guide lifestyle, diet and nutritional supplement decisions to improve the overall health and well-being of patients.

Standard Process

Standard Process will offer Pathway OME FIT and SkinFIT tests to their network of practitioners and patients. These tests will provide evidence-based, personalized, actionable information and product recommendations, based on patients’ genetic results that helps them adjust their lifestyle, diet, habits and activities to improve their overall quality of life. Each test analyzes variations in 70+ key genes in many domains of health: Eating Behaviors, Diets and Diet plans, Lipid and Sugar metabolism, Skin Photoaging and Hydration, Micronutrients, Inflammation and Exercise.

“This is a very exciting step that allows us to provide practitioners and patients with advanced insight into a patient’s metabolism,” says John Troup, PhD, Standard Process Vice President of Clinical Science, Education & Innovation. “With the genetic results and AI analysis from Pathway OME, we will be able to bridge the gap between individual metabolism and healthcare while providing more personalized nutritional support.

“We know Standard Process as the visionary leader in clinical nutrition therapies and personalization based on whole food nutrition solutions,” says Dr. Michael Nova, Pathway OME Chief Innovation Officer and Founder. “We are proud that FIT and SkinFIT will now be able to help Standard Process healthcare practitioners and patients identify variations in gene networks that influence health and wellness.”

Rainbow Genomics

Asian Genetic testing company Rainbow Genomics will introduce the Pathway OME SkinFIT test and services to physicians and patients in Asia. This test is the newest and most advanced skin genetic test providing an in-depth understanding of how DNA impacts skin and overall nutritional health. SkinFIT analyzes variations in 70+ key genes covering 23 conditions across many domains of skin health: Photoaging and Hydration, Micronutrients and Inflammation including eczema, psoriasis and contact dermatitis conditions. SkinFIT also provides verified ingredient and product recommendations for optimal skin health.

With the current personalized health care trend, Pathway OME offers more than just results, but a comprehensive plan that will impact overall health and wellness. For example, the test also recommends 14 clinical procedures associated with the skin health and allergy findings to assist physicians in choosing an optimal skin care strategy. Rainbow Genomics will provide localized support to physicians, including translated clinical reports in Chinese and Japanese, “easy-to-understand” guidelines on dietary and lifestyle improvement, and peer-to-peer consultation.

“Unlike many direct-to-consumer skin genetic tests that deliver reports lacking clinical evidence, the SkinFIT test is unique in that it delivers evidence-based results specific for Asians, with recommended clinical procedures helping physicians to provide optimal skin care,” said Daniel Siu, CEO of Rainbow Genomics.

“We are delighted to partner with Rainbow Genomics, one of the leading pioneers of Next Generation Gene-Sequencing diagnostic services for health screening in all of Asia,” said Michael Nova, MD, Chief Innovation Officer and Founder of Pathway OME. “Rainbow has been at the forefront of providing U.S. based clinical applications throughout Asia and partnering with Rainbow enables us to offer an AI-driven, accessible, affordable, and clinical grade wellness services to our clients in the Asia-Pacific region.”

Pathway OME DNA tests are available at CVS pharmacies nationwide, Amazon, Walmart.com and Pathway.com.

About Pathway OME

Founded in 2009, Pathway Genomics (Pathway.com) has become known for its dedication to innovation – making it a leader in the commercial personalized health and wellness industries. Focusing on providing users with the most validated and personalized healthcare information delivered to any device, the company’s program with IBM data is the first of its kind to merge artificial intelligence (AI) and deep learning with precision medicine, applicable to both consumers and providers. Pathway OME DNA tests are available at CVS pharmacies nationwide, Amazon, Walmart.com and Pathway.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181016006022/en/